Assay News and Research

RSS

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Talk to focus on the spinout journey from drug repurposing to clinical trials for diagnosing and treating Alzheimer’s Disease.

28 Nov 2023

Potential breakthrough in breast cancer: Five proteins identified as risk markers

Researchers used a Mendelian randomization approach to conduct a genetic association analysis of the levels of over 3,000 proteins to identify biomarkers for early breast cancer detection.

28 Nov 2023

Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Dietary components that impact anti-tumor immunity.

28 Nov 2023

Fiber-free diet key to treating childhood Crohn's disease, new study finds

Research reveals how a fiber-free diet in Exclusive Enteral Nutrition (EEN) helps treat Crohn's disease in children by affecting the intestinal pathobiont Mucispirillum schaedleri. It shows that this diet alters gut microbiota, reducing Mucispirillum's pathogenicity and aiding in managing colitis.

26 Nov 2023

Study demonstrates prolonged persistence of enteroviruses on commonly encountered surfaces

Hand, foot, and mouth disease (HFMD) is a contagious disease that mainly affects young children in the Asia-Pacific region.

23 Nov 2023

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

CN Bio has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN Awards.

From CN-Bio 23 Nov 2023

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

In this Interview, Dr. Fang-Yi Chu talks to NewsMed about the role of transmembrane proteins in targeting oncology research.

From Sino Biological Inc. 23 Nov 2023

Integra Launches Sterile Polypropylene Reagent Reservoirs With Sureflo™ Technology

INTEGRA Biosciences has extended its reagent reservoir portfolio to include 10 and 25 ml sterile polypropylene reservoirs with SureFlo™ anti-sealing technology.

From INTEGRA Biosciences 23 Nov 2023

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

The impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4+ (CD4+ ) Thymus cells (T cells) viz.

21 Nov 2023

Researchers develop machine learning-based tool for assessment of shoulder function

A study published in Scientific Reports introduces a simple string-pulling task as a reliable method for assessing shoulder mobility in both animals and humans. This innovative approach, combined with machine learning, has the potential to revolutionize the diagnosis and monitoring of shoulder injuries, offering an affordable and accessible solution.

19 Nov 2023

Injectable grain-of-rice-sized glucose monitor could revolutionize diabetes management

The first glucose self-monitoring system created in 1970 weighed three pounds, was initially designed only for physicians' offices and needed a large drop of blood for a reading.

17 Nov 2023

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Study discovers that coffee, especially its bioactive compounds like chlorogenic acids, can inhibit SARS-CoV-2 entry and reduce ACE2 and TMPRSS2 levels, indicating that coffee intake might be a potential dietary strategy for COVID-19 prevention.

16 Nov 2023

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival rates in patients with microsatellite stable metastatic colorectal cancer, showing manageable safety and notable increases in progression-free and overall survival.

15 Nov 2023

Senolytics show promise in combating brain aging and COVID-19 neuropathology

Study reveals that senolytics can reduce aging in human brain organoids and mitigate COVID-19 neuropathology, suggesting their potential as a therapeutic strategy against brain aging and coronavirus-related neurological complications.

15 Nov 2023

CVD-21: A novel instrument for predicting and monitoring cardiovascular disease

Researchers at Uppsala University have developed an instrument that makes it possible to measure 21 biomarkers for cardiovascular disease simultaneously with great precision by means of a simple blood test.

15 Nov 2023

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease

Whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson's disease (PD).

15 Nov 2023

Novel assay may improve detection and treatment of acute myeloid leukemia

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier.

13 Nov 2023

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

In a JAMA Network Open study, researchers found no evidence of neuroinflammation or blood-brain barrier dysfunction in cerebrospinal fluid markers of individuals with post-COVID-19 condition and neuropsychiatric symptoms compared to controls. The study, which assessed cytokines, chemokines, and neuroinflammation markers, suggests that persistent central nervous system immune activation may not be the primary driver of neurological long COVID symptoms.

13 Nov 2023

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract.

From ATCC 13 Nov 2023

Pioneering study finds predictive biomarker in lung adenocarcinoma

The potential of the transcriptome of tumor-adjacent normal lung tissue in predicting the prognosis of lung cancer.

13 Nov 2023

Assay News and Research

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Potential breakthrough in breast cancer: Five proteins identified as risk markers

Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Fiber-free diet key to treating childhood Crohn's disease, new study finds

Study demonstrates prolonged persistence of enteroviruses on commonly encountered surfaces

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

Empowering oncology research: Transmembrane proteins and cutting-edge production platforms

Integra Launches Sterile Polypropylene Reagent Reservoirs With Sureflo™ Technology

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

Researchers develop machine learning-based tool for assessment of shoulder function

Injectable grain-of-rice-sized glucose monitor could revolutionize diabetes management

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

Senolytics show promise in combating brain aging and COVID-19 neuropathology

CVD-21: A novel instrument for predicting and monitoring cardiovascular disease

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease

Novel assay may improve detection and treatment of acute myeloid leukemia

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development

Pioneering study finds predictive biomarker in lung adenocarcinoma

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News